Giuseppe Fracchiolla
Overview
Explore the profile of Giuseppe Fracchiolla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barbarossa A, Rosato A, Tardugno R, Carrieri A, Corbo F, Limongelli F, et al.
Microorganisms
. 2025 Feb;
13(2).
PMID: 40005818
The global rise in antimicrobial resistance poses a significant threat to public health, necessitating alternative therapeutic options. One critical challenge is treating infections caused by biofilm-forming bacteria, which are notably...
2.
Mallamaci R, Castellani S, Limosani F, Medaglia P, Fracchiolla G, Cardone R, et al.
Int J Pharm
. 2025 Feb;
673:125399.
PMID: 39999902
The aim of the present work was to evaluate the performance of slightly viscous dispersions (SVDs) of the mucoadhesive oxidized alginate (Alg OX) with or without hydroxypropylmethyl cellulose (HPMC) as...
3.
Barbarossa A, Rosato A, Carrieri A, Fumarola L, Tardugno R, Corbo F, et al.
Pharmaceuticals (Basel)
. 2024 Sep;
17(9).
PMID: 39338275
The emergence and spread of drug-resistant pathogens, resulting in antimicrobial resistance, continue to compromise our capability to handle commonly occurring infectious diseases. The rapid global spread of multi-drug-resistant pathogens, particularly...
4.
Lanave G, Pellegrini F, Triggiano F, De Giglio O, Lucente M, Diakoudi G, et al.
Antibiotics (Basel)
. 2024 Jun;
13(6).
PMID: 38927181
The hepatitis C virus (HCV) is a major hepatotropic virus that affects humans with increased risk of developing hepatocellular carcinoma. The bovine viral diarrhea virus (BVDV) causes abortion, calf mortality...
5.
Castellani S, Mallamaci R, De Giglio E, Caponio A, Guerra L, Fracchiolla G, et al.
Int J Pharm
. 2024 May;
659:124255.
PMID: 38782151
With the aim to find an alternative vehicle to the most used thermosensitive hydrogels for efficient nanotechnology-based nose-to-brain delivery approach for Parkinson's disease (PD) treatment, in this work we evaluated...
6.
DAlessandro A, Desantis S, Fracchiolla G, Porrelli R, Dibenedetto R, Di Luca A, et al.
Res Vet Sci
. 2024 May;
174:105294.
PMID: 38744020
This study aimed to evaluate the effects of a mixture of olive, laurel, and rosemary leaf powders, on the oxidative state, biochemical, immune, intestinal morphophysiological parameters, and egg quality of...
7.
Lanave G, Catella C, Catalano A, Lucente M, Pellegrini F, Fracchiolla G, et al.
Heliyon
. 2024 May;
10(9):e30492.
PMID: 38711631
Norovirus (NoV) causes serious gastrointestinal disease worldwide and is regarded as an important foodborne pathogen. Due the difficulties of cultivation for human NoV, alternative caliciviruses (i.e., feline calicivirus, FCV, or...
8.
Mallamaci R, Musaro D, Greco M, Caponio A, Castellani S, Munir A, et al.
Molecules
. 2024 Apr;
29(8).
PMID: 38675592
Parkinson's disease (PD) is a prevalent neurodegenerative disorder, primarily associated with dopaminergic neuron depletion in the Substantia Nigra. Current treatment focuses on compensating for dopamine (DA) deficiency, but the blood-brain...
9.
Barbarossa A, Rosato A, Carrieri A, Tardugno R, Corbo F, Clodoveo M, et al.
Antibiotics (Basel)
. 2023 Dec;
12(12).
PMID: 38136707
Systemic fungal infections have risen in recent decades and most of them are caused by species, which are becoming increasingly resistant to conventional antifungal drugs. Biofilm production has been considered...
10.
Martemucci G, Fracchiolla G, Muraglia M, Tardugno R, Dibenedetto R, DAlessandro A
Antioxidants (Basel)
. 2023 Dec;
12(12).
PMID: 38136211
Metabolic syndrome (MS) is a growing disorder affecting thousands of people worldwide, especially in industrialised countries, increasing mortality. Oxidative stress, hyperglycaemia, insulin resistance, inflammation, dysbiosis, abdominal obesity, atherogenic dyslipidaemia and...